Geode Capital Management’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Buy |
174,779
+2,322
| +1% | +$2.02K | ﹤0.01% | 3955 |
|
|
2025
Q1 | $295K | Buy |
172,457
+5,778
| +3% | +$9.88K | ﹤0.01% | 3725 |
|
|
2024
Q4 | $350K | Buy |
166,679
+16,288
| +11% | +$34.2K | ﹤0.01% | 3710 |
|
|
2024
Q3 | $459K | Buy |
150,391
+35,608
| +31% | +$109K | ﹤0.01% | 3611 |
|
|
2024
Q2 | $319K | Buy |
114,783
+15,445
| +16% | +$43K | ﹤0.01% | 3739 |
|
|
2024
Q1 | $361K | Buy |
99,338
+45,746
| +85% | +$166K | ﹤0.01% | 3727 |
|
|
2023
Q4 | $67K | Buy |
53,592
+6,176
| +13% | +$7.72K | ﹤0.01% | 4282 |
|
|
2023
Q3 | $47K | Sell |
47,416
-1,421
| -3% | -$1.41K | ﹤0.01% | 4433 |
|
|
2023
Q2 | $35.3K | Hold |
48,837
| – | – | ﹤0.01% | 4577 |
|
|
2023
Q1 | $133K | Hold |
48,837
| – | – | ﹤0.01% | 4233 |
|
|
2022
Q4 | $119K | Sell |
48,837
-165
| -0.3% | -$402 | ﹤0.01% | 4330 |
|
|
2022
Q3 | $120K | Sell |
49,002
-924
| -2% | -$2.26K | ﹤0.01% | 4487 |
|
|
2022
Q2 | $148K | Buy |
49,926
+924
| +2% | +$2.74K | ﹤0.01% | 4419 |
|
|
2022
Q1 | $161K | Hold |
49,002
| – | – | ﹤0.01% | 4476 |
|
|
2021
Q4 | $198K | Hold |
49,002
| – | – | ﹤0.01% | 4472 |
|
|
2021
Q3 | $306K | Sell |
49,002
-1,383
| -3% | -$8.64K | ﹤0.01% | 4260 |
|
|
2021
Q2 | $352K | Buy |
+50,385
| New | +$352K | ﹤0.01% | 4095 |
|